CRIS
CurisDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
Current thesis
Composite grade D from latest DB weights. Momentum 14.4 / Value 58.8
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.2.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
14
Value
59
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-22
Fundamentals
As of 2026-07-21 • Vendor: Data Vendor v1
Scores
As of 2026-07-22 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-22
Investment thesis
As of 2026-07-22
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $280.00
Why
Momentum14 · Δ7d -
Value59 · Δ7d +0.2
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
14
40% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
59
60% active weight
Current posture
7d trendFlat
Δ7d
+0.2
Δ21d
+17.6
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 14.4 / Value 58.8
Fundamentals (TTM)As of 2026-07-21
Fundamentals (TTM)
As of 2026-07-21
Market Cap
$9.26M
Beta
3.07
Shares Out
1.95M
P/E (TTM) · Derived
-0.4
P/S (TTM)
1.09
P/FCF (TTM) · Derived
-2.56
Rev YoY
-100.0%
EPS YoY
-0.0%
Gross Margin
+97.9%
Op Margin
-294.6%
Net Debt
-$3.44M
Current Ratio
1.11
As of 2026-07-22 • Updated nightlySource: Internal modelMethodology